NANOMEDICINE

Nanomedicine Workshop provides medical doctors, engineers, scientists, new researchers and stakeholders from different disciplines with a unique and exciting format to learn the most current information about nanomedicine advances in the early diagnosis and treatment of diseases. It will be a perfect platform to share, experience, foster collaborations across health care, pharmaceutical, biotech & diagnostic industries with hospitals and academia.

There is an enormous gap between clinical practice and Nanosciences & Nanotechnologies. This workshop attempts to fill this gap more perfectly and more currently by enlisting world-renowned speakers and stakeholders in Nanomedicine with up-to-date information towards unmet clinical needs. It will feature a scientific program of comprehensive talks, special sessions, debates, oral and poster presentations of peer-reviewed contributions to showcase the most recently breaking research development, discovery, industrial progress and milestones in Nanomedical, Nanobiotechnology, Regenerative Medicine and Nanopharmaceutics R & D.

Nanomedicine Workshop will address progress and prospects for nanomedicine including, in-vitro and in-vivo diagnostics, biosensors, imaging, targeted drug delivery, nanomaterials, regenerative medicine. Updates on preclinical and clinical trials, clinical hurdles in a wide spectrum of diseases (Oncology, Cardiovascular Disease, Orthopaedics, Neurodegenerative, Infections, Diabetes, Ophthalmology, etc) and nanomedicine- oriented solutions will be presented. Nanotoxicology and ethics will constitute the controversial issues to be discussed.

Together with the co-located Bioelectronics Workshop, it will provide the latest advances in biosensors and bioactuators from bench to bedside. Fundamentals of biosensor design and manufacturing will be covered and translated into clinical applications.

The Nanomedicine Workshop covers (but not limited to) the following key topics:

Basics related to Medicine, Biology, and Nanotechnology

• Nanotechnology in Biology
• Biological Systems (from biomolecules to cells and organisms) and Biological Structures
• Self-assembly and self-organization
• Nanobiotechnology
• Nanotechnology for Health and Food products
• Cell/Nanomaterial Interactions
• Nanophotonics in nature and adapted to biomimetic and biosensors for active nanosystems
• Biomechanics
• 3D Bioprinting

Nanobiomedicine

• Nanoimaging and therapy
• Nanoinformatics
• Clinical Nanomedicine
• Nanomedicine-based cancer immunotherapy
• Stimuli-responsive nanosystems
• CRISPR-Cas NPs in cancer immunotherapy
• Biomimetic NPs for cancer immunotherapy

Biosensors

• Biosensors & bioelectronics
• Biosensor packaging and assembly
• Microfluidics biosensors

Nanomaterials in any form

• Nanostructures for medical applications
• Nanofibres, Nanoparticles, and Nanotubes

Clinical Applications

• Versatile Nanotech tools and nanomaterials in Medicine
• Biomaterials and Nanomaterials for biosensing, imaging, diagnostic and vectorization
• In-vitro Diagnostics: Biosensors, Lab-on-chips, biomarkers
• In-vivo Diagnostics and imaging
• Targeted Drug Delivery
• Regenerative Nanomedicine
• Stem Cells, Cellular & Tissue Engineering
• Nanodrugs and Nanopharmacy
• Nanodentistry
• Nanomedicine Targeting Major Diseases (Cardiovascular, Oncology, Diabetes, Orthopaedics, Neurodegenerative, Infections, Hematology, Ophthalmology, etc)

Update on Preclinical and Clinical trials on Nanomedicine

Nanotoxicity, Risk Assessment and Ethics

Commercialization in Nanomedicine

 

WORKSHOP 3 COMMITTEE (tentative)

V. Karagkiozaki (Chair), Nanotechnology Lab LTFN and AHEPA Hospital AUTh, Greece
T. Mitsiadis (co-Chair), Uni of Zurich, Switzerland
A. Alexandrou, Lab for Optics & Biosciences, Ecole Polytechnique, France
N. Baldini, Uni of Bologna and Istituto Ortopedico Rizzoli, Italy
L. P. Balogh, Precision Nanomedicine, USA
E. Chang, Dept of Oncology, Lombardi Comprehensive Cancer Center, Georgetown Uni, USA
Th. Choli – Papadopoulou, Chemistry Dept, AUTh, Greece
G. Kousoulas, Division of Biotechnology & Molecular Medicine, Louisiana State Uni, USA
M. Masserini, Medical School- Uni of Milan Bicocca, Italy
H. J. Meisel, Department of Neurosurgery, BG-Clinic Bergmannstrost, Germany
Y. Missirlis, Lab of Biomechanics & Biomedical Engineering, Uni of Patras, Greece
A. Mikos, Rice Uni, USA
M. Tanaka, Kyushu Uni & Uni of Yamagata, Japan

---

Organized by:

	EU H2020-FlexFunction2Sustain: "Open Innovation Ecosystem for Sustainable Nano-functionalized Flexible Plastic and Paper Surfaces and Membranes" www.flexfunction2sustain.eu

Supported by: